Scholars Central

Review articlePublished 2014

Adoptive Immunotherapy for Acute Myeloid Leukemia: From Allogeneic Hematopoietic Cell Transplantation to CAR T Cells

Authors: Merav Bar

Journal of Leukemia

Volume 2 · Issue 2 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Allogeneic Hematopoietic Cell Transplantation (allo-HCT) has improved outcome of patients with high risk Acute Myeloid Leukemia (AML), but it harbors a risk of morbidity and mortality due to damage to normal cells and tissues by the high intensity conditioning or due to Graft Versus Host Disease (GVHD). As a major component of the curative potential of allo-HCT is derived from the response of the donor immunity against the malignant cells through the so called Graft Versus Leukemia effect (GVL), novel adoptive immunotherapy strategies have been developed to generate immune response against the leukemic cells, while sparing GVHD.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Leukemia
  • SubjectHaematology
  • BylineArticles whose byline prints “Merav Bar”